The MUSE procedure from medical device company Medigus is an incisionless procedure.
“I was able to complete a single procedure in about one hour, since the device is fully integrated with all capabilities and the treatment can be administered by a single physician. Because it requires no incisions, the patients reported greater comfort during treatment, their hospital stays were reduced by 50 percent through treatment with MUSE over more invasive fundoplication procedures, and they were able to return to most of their daily activities after about a week,” said Professor Testoni.
More articles on gastroenterology:
Loyola University Health System adds Dr. Lesley Rhee
PPACA repeal: How would gastroenterologists be impacted?
Mid-South Gastroenterology Group partnerships aim to increase colonoscopies
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.